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Abstract
Background: The official WHO estimates of preterm birth are an essential global resource for assessing the burden
of preterm birth and developing public health programmes and policies. This protocol describes the methods that
will be used to identify, critically appraise and analyse all eligible preterm birth data, in order to develop global,
regional and national level estimates of levels and trends in preterm birth rates for the period 1990 – 2014.
Methods: We will conduct a systematic review of civil registration and vital statistics (CRVS) data on preterm birth
for all WHO Member States, via national Ministries of Health and Statistics Offices. For Member States with absent,
limited or lower-quality CRVS data, a systematic review of surveys and/or research studies will be conducted.
Modelling will be used to develop country, regional and global rates for 2014, with time trends for Member States
where sufficient data are available. Member States will be invited to review the methodology and provide
additional eligible data via a country consultation before final estimates are developed and disseminated.
Discussion: This research will be used to generate estimates on the burden of preterm birth globally for 1990 to
2014. We invite feedback on the methodology described, and call on the public health community to submit
pertinent data for consideration.
Trial registration: Registered at PROSPERO CRD42015027439
Contact: pretermbirth@who.int
Keywords: National, Regional, Global, Preterm birth, Estimates, Trends
Background
Background, rationale, aims and objectives
Preterm birth (PTB) is defined by WHO as all births before
37 completed weeks of gestation [1]. Preterm neonates are
at an increased risk for a wide range of short- and long-
term respiratory, infectious, metabolic and neurological
morbidities, with higher risks of adverse outcomes seen at
lower gestational ages [2, 3]. Of the estimated 6.3 million
children under 5 who died in 2013, 15.4 % (0 · 965 million,
uncertainty range 0 · 615–1 · 537 million) were due to com-
plications of preterm birth; it is the leading cause of death
amongst neonates (death in the first 28 days of life) [4].
The WHO estimates are an important resource for
assessing the burden of preterm birth at global, regional
and national levels, and how that burden is changing
over time. Also, they aid development and implementa-
tion of health policies, inform resource allocation in
health systems, and can be used to assess the impact of
interventions. The estimates are also an important tool
in raising awareness of preterm birth as an important
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global public health issue. Two systematic analyses of
preterm birth estimates have been published previously
[5, 6]. The most recent estimates were published in 2012
(covering data for the period 1990–2010) by Blencowe
and colleagues [6]. They estimated that 14 · 9 million ba-
bies (uncertainty range 12 · 3–18 · 1 million) were born
preterm in 2010, accounting for 11 · 1 % of all live births
worldwide. In the 65 countries with reliable time trend
data for preterm birth, 62 countries had increasing rates
from 1990 to 2010. However, these preterm birth esti-
mates now require updating, in light of new data and
continued refinements in statistical modelling methods.
The aim of this study is to develop national, regional
and global estimates of preterm birth for all WHO
Member States, for the period 1990–2014. This protocol
describes the methods that will be used to identify and
analyse all eligible data on preterm birth.
The objectives are:
1. To conduct a systematic review of all available data
on preterm birth rates;
2. To critically appraise and synthesize eligible data,
and conduct modelling to develop estimates of levels
and trends of preterm birth rates at national,
regional and global levels; and
3. To disseminate preterm birth estimates, in order to
inform WHO Member States and other entities in
the development of public health programmes and
policies.
Concepts and definitions
The International Statistical Classification of Diseases
and Health Problems, 10th revision (ICD-10) [7] uses the
WHO definition of preterm birth, namely: “All births be-
fore 37 completed weeks of gestation or fewer than
259 days since the first day of a woman’s last menstrual
period” [1]. The WHO definition does not define a lower
gestational age limit for reporting; ICD-10 advises inclu-
sion of all live births (regardless of gestational age).
Preterm birth can be further sub-divided based on ges-
tational age:
 Extremely preterm (<28 completed weeks of
gestation)
 Very preterm (28 - <32 weeks completed weeks of
gestation)
 Moderate preterm (32 - <34 completed weeks of
gestation)
 Late preterm birth (34 - <37 completed weeks of
gestation)
WHO recommends reporting the preterm birth rate
using the following indicator (Table 1), which will be the
primary outcome for these estimates.
Factors affecting standardization, measurement and
comparison of the live preterm birth rate
Preterm birth includes both spontaneous preterm birth
and provider-initiated preterm birth [8]. Spontaneous
preterm birth includes both women in spontaneous pre-
term labour with intact membranes, and women with
preterm prelabour rupture of membranes. Provider-
initiated preterm birth includes women in whom the
preterm delivery is initiated (either by induction of
labour or caesarean section) for maternal or fetal indica-
tions. While it is often stated that approximately 20–
30 % of preterm births are provider-initiated [8, 9], this
can vary greatly between countries, and is significantly
lower in many lower-income countries [10].
The pathophysiology of spontaneous preterm birth is
not fully understood and several pathways have been
identified [8]. While many socio-demographic, nutri-
tional, medical, obstetric, biological and environmental
factors increase the risk of preterm birth, many women
who deliver preterm who do not have a clear risk factor.
Developing estimates is further complicated by several
factors that can impede accurate preterm birth data
measurement, estimation and comparison:
 The risk of preterm birth can be higher in some
disadvantaged sub-populations (including poor, un-
educated, rural-dwelling women or other minorities)
where data collection may be more limited and/or
facility-based births are less common;
 Misclassification of live births, stillbirths and
neonatal deaths can also impact on accurately
recording the liveborn preterm birth rate. As the
risk of stillbirth is higher in earlier gestation,
measuring the liveborn preterm birth rate can
underestimate the total preterm birth burden; [11]
 National differences in the definition of preterm
birth (for example, using live births or total births as
the denominator, and different gestational age
thresholds for defining preterm birth cases), and the
relevant lower gestational age boundary for
registration can complicate comparisons;
 Similarly, countries with a lower gestational age
boundary for birth registration (i.e. viability) will
capture a larger absolute number of births and
preterm births. However, this can also potentially
improve preterm birth registration rates at higher
gestational ages [6].
 Gestational age (GA) estimation error is also an
important factor. Generally, the later in pregnancy a
Table 1 WHO preterm birth rate indicator
number of liveborn preterm births (singleton or multiple)
number of live births (singleton or multiple)
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GA estimate is made, the wider the uncertainty of
that estimate. Routine early pregnancy ultrasound with
fetal biometric measurements is considered the “gold
standard” for gestational age assessment [12]. However,
other methods such as calculation from date of last
menstrual period (LMP), symphysis-fundal height
measurement, postnatal examination of the newborn,
or use of birthweight as a gestational age surrogate are
often used in resource-limited settings. Many countries
report the use of “best obstetric estimate” of gestational




There are two broad categories of preterm birth data
available:
1. Routinely collected birth data, available from
national Ministries of Health or statistical offices
(civil registration vital statistics); or
2. Data from published research studies
For this study, high-quality, civil registration vital statis-
tics (CRVS) data is the preferred data source. Civil registra-
tion is defined by the United Nations as the “continuous,
permanent, compulsory and universal recording of the oc-
currence and characteristics of vital events […] pertaining
to a population” [14]. However, for many countries, CRVS
data on preterm birth will be incomplete, of poor quality or
not available [15]. In countries with absent or limited CRVS
data, data from research studies will be required.
While reproductive health surveys may use population-
based random sampling and have large sample sizes, they
generally rely on maternal recall and knowledge of pre-
term birth, and hence may have poor accuracy and limited
utility. Conversely, facility-based studies, particularly in
settings where early antenatal care participation is high
and obstetric ultrasound is available, may have greater ac-
curacy in estimating GA and diagnosing preterm birth,
however they often have smaller sample sizes and may not
be representative of the general population. Consequently,
it is difficult to ascertain whether certain data sources or
study designs are more useful, or should supersede, other
sources. Initially, we intend to be over-inclusive (in terms
of study designs) and conduct necessary exploratory ana-
lyses of all included data, to explore the quality, represen-
tativeness and utility of identified data. This may result in
later exclusion of certain data sources.
Following the identification and extraction of relevant
data, statistical analysis and modelling will be completed
to develop estimates of levels of preterm birth at global,
regional and national levels, with trends at national level
where sufficient data is available. The methodology and
preliminary estimates will then be reviewed by a tech-
nical advisory group (TAG) (an independent group of
experts in obstetrics, neonatology, statistics and pre-
term birth research). The TAG will advise if any
modifications are required. As per WHO standards in
developing official estimates, we will also conduct a
country consultation process, whereby WHO Member
States are invited to review their preliminary esti-
mates and submit any additional data not identified
in the search. From this, final estimates will be devel-
oped and disseminated. This protocol has been pre-
pared according to the Preferred Reporting Items for
Systematic reviews and Meta-Analyses for Protocols
(PRISMA-P) 2015 statement [6].
Eligibility criteria
For searches of CRVS and study data, the following eligi-
bility criteria will be used:
Population
Liveborn neonates (singleton and/or multiple). Data
reported using a related or similar definition of pre-
term will also be included. This includes preterm
birth for all births (rather than live births only),
singletons only, non-malformed fetuses only, or
<36 weeks gestation. Women, pregnancies or new-
borns of non-generalizable sub-populations (such as
those with specific medical or obstetric complications
only, women or newborns using speciality services,
selected sociodemographic groups, sub-groups based
on maternal age or otherwise high-risk or selected
populations) will not be included. Studies of low-risk
populations only will be included.
Setting
Data from national or subnational level (including
population-based, community-based and facility-based
data) for the 194 Member States of WHO [16] will be
considered for inclusion.
Study design
Any study design capable of producing usable data on
preterm birth will be eligible for inclusion (e.g. surveys,
cross-sectional studies, interventional studies) regardless
of the context or the setting (e.g. nationwide, facility-




○ Preterm birth rate (in all live births, according
to the WHO definition)
 Secondary outcomes:
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○ Preterm birth in all births (liveborns and
stillborns)
○ Extremely preterm (<28 completed weeks)
○ Very preterm (28 - <32 completed weeks)
○ Moderate preterm (32 - <34 completed weeks)
○ Late preterm birth (34 - <37 completed weeks)
○ Spontaneous and provider-initiated preterm
birth (<37 completed weeks)
Timeframe
All available data on preterm birth from 1990 to 2014.
Languages
No language restriction will be applied.
Sample size
There is no established method for defining a minimum
sample size per data source for the development of glo-
bal estimates. Previous preterm birth estimates have
used cut-offs of 50 births [6] or 200 births [5] for inclu-
sion; the 2012 estimates also used a cut-off of data ob-
tained over ≥12 months [6]. For these estimates, a lower
limit of 500 births (without time restriction) was selected
as a cut-off by consensus of the working group, based
on the following rationale:
 Smaller studies may be more susceptible to bias
(eg: selection bias);
 Based on the 2012 estimates [6], it is likely that or
more covariates will be required to estimate the
preterm birth rate. Assuming a minimum of ten
preterm birth cases per covariate, 50 preterm birth
cases would be needed. Assuming a preterm birth
rate of approximately 10 %, this equates to 500
births in total per dataset.
Classification of countries for assessing reliability and
quality of available data
Different global estimates have used different methods
of categorizing or stratifying countries on the basis of
available data [6, 17, 18], depending on the outcome of
interest. For example, previous maternal mortality esti-
mates have used a three-level system for categorizing
countries on the basis of the quality of mortality data
reporting [18]. However, birth registration levels are gen-
erally higher than those of death and cause-of-death
registration [19]. Classifying countries on the basis of
cause-of-death completeness is probably not an appro-
priate proxy for the capture of data related to preterm
birth.
For the purposes of developing preterm birth esti-
mates, high-quality CRVS data on births should have
both reasonably high coverage and completeness, as well
as reporting the necessary data to determine the preterm
birth rate and the method/s of gestational age assess-
ment. However, lower-quality CRVS data on preterm
births may still be useful as an input for statistical
models.
The WHO Global Health Observatory reports national
estimates of civil registration coverage of births [20].
This country level indicator is derived from assessments
of civil registration systems, and/or from population-
based household surveys that report on proportion of
births registered. The latest World Health Statistics Re-
port (2015) [21] also reports on this indicator (for coun-
tries where data is available) based on data from the
period 2007 to 2013. This indicator will be used as a
proxy for identifying countries likely to have higher-
quality CRVS data for preterm births for the period of
interest (see Table 2 below). For countries where data is
not available, we will consult with relevant WHO tech-
nical staff to inform correct categorization.
We plan to classify all WHO Member States into
Groups A, B and C, on the basis of: whether CRVS data
is available on preterm birth, the coverage of the civil
registration system for births, and the volume of the
CRVS preterm birth data available. Hence:
 Group A: Countries with CRVS birth registration
coverage is over 80 %, and CRVS preterm birth data
is available for > =50 % of years from 1990 to 2014
inclusive;
 Group B: Countries with CRVS birth registration
coverage from 60 to 80 %, and/or CRVS preterm
birth data is available for <50 % of years from 1990 to
2014 inclusive (or otherwise ineligible for Group A);
 Group C: Countries with CRVS birth registration
coverage below 60 % or unknown, and/or no CRVS
data for preterm birth is available (or otherwise
ineligible for Group A and B).
The overview of this categorization is provided in
Table 3. In some instances, expert judgment from WHO
technical staff may be used to further inform correct
categorization. Countries in Group A will be considered
as having high-quality data for preterm birth, and no fur-
ther searching will be conducted (i.e. CRVS data only will
be used for these countries). For countries in Groups B
Table 2 Civil registration coverage of births for 194 WHO
Member States [21]
Civil registration coverage of births (%) Number of countries (%)
>80 % coverage 126 (64.9 %)
60 % - ≤80 % coverage 23 (11.9 %)
<60 % coverage 29 (15.0 %)
No data 16 (8.2 %)
Total 194 WHO Member States
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and C, available CRVS data will be used as inputs for stat-
istical models, however further searching (systematic re-
view of available literature) will be conducted for these
countries. It is envisaged that some CRVS data may be of
such poor quality that it cannot be used, and will be
excluded.
The systematic review of data from Group B and C
countries will consider both interventional and obser-
vational designs (case-control studies will be specific-
ally excluded) presenting original quantitative data on
preterm birth. If intervention studies are included, all
arms will be considered for inclusion. However, if the
preterm birth rate is significantly different between
arms (or the significance is unknown), only the con-
trol arm/s will be used.
Search strategy and classification of countries
CRVS data will be obtained through online searching of
national Ministry of Health and national statistical office
publications and datasets for every WHO Member State.
A review of references from the 2012 WHO preterm
birth estimates activity [6] will be used to supplement
this search, as will eligible data from the country con-
sultation (see below).
For the systematic review of published studies, the fol-
lowing databases will be searched: Medline, EMBASE,
Popline, WHO Global Health Library (including re-
gional and global indexes), CINAHL, PsychInfo, and the
Cochrane Central Register of Controlled Trials (CEN-
TRAL). Citations from previous systematic reviews of
levels and trends of preterm birth will also be reviewed
[5, 6]. A pro forma email specifying our analysis objec-
tives and inclusion criteria will be developed and circu-
lated to further identify data. We will contact key
stakeholders working in each country and in maternal
and neonatal health research networks in countries
where little or no data is available, in order to further
identify additional unpublished datasets (if available).
Given the population size of China, and the lack of a na-
tional CRVS data on preterm birth, we will conduct a
separate search of Chinese language health and medical
databases, using the same protocol.
Screening, data selection and collection process
Two reviewers will independently screen all citations
(title and abstract) identified through the searches, to as-
sess for potential eligibility. In the case of disagreement
or where the information is not sufficient for decision
on inclusion/exclusion, the article will be included for
full text review. Full texts of potentially eligible studies
or sources will be retrieved and independently assessed
for inclusion by two reviewers. Any discrepancies will be
resolved by discussion and consensus by the two re-
viewers or through consultation with a third reviewer.
Where citations are excluded at this step, the reason for
exclusion will be documented.
Table 3 Categories and criteria for Groups A, B and C in WHO preterm birth estimates
WHO Member States
Group A country Group B country Group C country





CRVS data for preterm birth are
available, ie: Preterm birth rate
is given or can be calculated
CRVS data for preterm birth are
available, ie: Preterm birth rate
is given or can be calculated
No CRVS for preterm birth available,
or CRVS data available but country








CRVS coverage for births >80 % [20]
(or country can be otherwise classified
as having high coverage for birth
registration)
CRVS coverage for births is
60 % - <80 % [20]
CRVS coverage for birth data is






• Commencement date of data collection
after 1/1/1990
• End date of data collection is before
31/12/2014
• Number of years where preterm
data available is >50 % for the period
1990 to 2014 inclusive (i.e. CRVS data
available for at least 13 years)
• ≥500 births
• Commencement date of
data collection after 1/1/1990
• End date of data collection
is before 31/12/2014
• Data for any year/s between
1990 to 2014 inclusive (but
does not meet Group A
criteria)
• No CRVS data on preterm birth
available, or
• CRVS data on preterm birth
available, but country does not
otherwise meet G




Data sources: CRVS data only to be used Conduct systematic review of
published studies to identify
additional data sources
Conduct systematic review of
published studies to identify
additional data sources
aCountries that have CRVS data for preterm birth, but CRVS coverage for birth data is <60 % or unknown, will be considered Group C countries
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We will develop a standard data extraction form
that will be pilot tested against both CRVS and study
data on preterm birth. Data extraction from the full
text articles will be done using this standard form via
an online data management database, completed inde-
pendently by two reviewers with the results com-
pared. In the event of disagreement, discrepancies will
be resolved by discussion and consensus, or by con-
sultation with a third reviewer. All data inclusion and
exclusion will be reported according to the PRIMSA
checklist.
Extracted data will include: country, data source,
design, time period, definition and methods used, range of
gestational age used, method of GA assessment, as well as
prevalence and incidence data on preterm birth (accord-
ing to primary and secondary outcomes) and covariate
data (see below).
Assessing quality of data sources
In this review we will potentially include data from a
range of study designs. However there is currently no
established tool for standardized assessment and com-
parison of quality across multiple study designs. To this
end, the WHO abortion estimates working group devel-
oped a data quality assessment tool, with the aim of
“systematic, quantitative, and efficient differentiation of
studies into different quality levels” (Tuncalp O, per-
sonal communication). The quality of data sources was
assessed using a five-point checklist, adapted from items
within the Strengthening the Reporting of Observational
Studies in Epidemiology (STROBE) statement. Items
were selected to assess quality in distinct sections of the
data source, to be relevant across a range of study de-
signs, and to be manageable in terms of time required to
conduct the quality assessment.
This has been reviewed and adapted for use in these
estimates. The checklist includes the following five
domains:
1. Eligibility criteria for the participants in the study
are provided;
2. Method of gestational age assessment (i.e.
measurement of the primary outcome) are provided;
3. Characteristics of study participants (e. g.
demographic, clinical, social) are provided;
4. The numbers of all outcome events/summary
measures are reported;
5. Authors discuss relevant sources of potential bias
and/or imprecision in the limitations/discussion.
Each item will be rated as met (1 point) or unmet/not
clear (0 point). Hence, for a given data source a max-
imum score of 5 is possible. Reviewers that extract data
will score the data source based on the above criteria.
Scores will be imputed by the reviewer into the data ex-
traction spreadsheet. In the case of disagreement, agree-
ment will be reached through consensus, or through
engaging a third reviewer.
Once completed, the score distribution will be
assessed and reported descriptively. Data sources with
the lowest scores will be re-evaluated; we will consider
excluding data sources on the basis of low quality. Sensi-
tivity analyses may also be used. These scores will not be
used for weighting in modelling.
Regions
Regions will be defined and reported according to mul-
tiple official groupings, including United Nations Re-
gional Groups, WHO Regions, Sustainable Development
Goal Regions, World Bank Regions and Income Groups,
and other UN agency regional groupings (UNFPA,
UNICEF, UNDP).
Covariates
In countries with little or no preterm birth data avail-
able, modelling the preterm birth rate on the basis of co-
variates will be required. Candidate predictors have been
preliminarily identified based on clinical relevance,
known risk factors for preterm birth and covariates iden-
tified in previous preterm birth estimates. These are:
 Neonatal mortality rate
 Low birthweight rate
 Caesarean section rate
 Multiple birth rate
 HIV prevalence rate (women 15–49 years old)
 Malaria rate (notified cases of malaria per 100,000
population)
 Proportion of women receiving four or more
antenatal care visits
 Mean adult female BMI
 Gross Domestic Product (GDP) per capita
 Total fertility rate
 Female literacy rate
 Human Development Index
 Maternal mortality ratio (MMR)
 Adolescent pregnancy rate
 Skilled birth attendance rate
 Facility delivery rate
 Gestational age range used by countries (for live birth
and preterm birth registration)
We aim to identify and extract available data on these
covariates from individual studies included in the system-
atic review. This will allow modelling using study-specific
covariate values. Additionally, it will permit a better de-
scription of the study database, identify potential selection
biases (i.e. selected populations) in identified studies,
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and also facilitate possible sensitivity or secondary ana-
lyses (if required). However, it is unlikely that individual
studies will contain data on all the covariates identified
above. We identified a shortlist of covariates where data
is likely to be available, which will be extracted from in-
dividual studies:
 Neonatal mortality rate
 Low birthweight rate
 Caesarean section rate
 Adolescent pregnancy
 HIV rate (for the study population)
 Malaria rate (for the study population)
 Proportion of women receiving four or more
antenatal care visits
Where study-specific covariate data are not available,
national estimates of covariates from the most compre-
hensive United Nations sources will be used.
Result
Statistical analysis and modelling
In the primary analysis all data (regardless of definition
of preterm birth) will be used. The WHO definition for
preterm birth rate will be the reference definition in the
analysis and for the presented results. Some data sources
may use alternative definitions of preterm birth, in
which case proportionate adjustment of the regression
models will be explored.
We hypothesize that the magnitude of associations be-
tween covariates and preterm birth are likely to vary by
region. Hence, we will develop region-specific models
(described below). However, once the database is assem-
bled, we will conduct exploratory analyses to assess
whether sufficient data exists to permit development of
these region-specific models and if not, a global model
will be developed.
For Group A countries, only CRVS data will be in-
cluded. For Group B & Group C countries, both CRVS
and study data will be included. All included data will
be analysed as described below (regardless of country
group). The predicted preterm birth rate for 2014 at na-
tional, regional and global levels will be presented. For
those countries with sufficient data, trends will also be
presented (see below). All analyses will be conducted
using Stata 14.
Preparation for analysis
To facilitate the development of models, we will obtain es-
timates of country level covariates from comprehensive,
publicly available United Nations sources. If country co-
variate data is missing for some countries and/or time-
points, these will be imputed based on separate regression
models. Where available, data on selected covariates will
also be extracted directly from data sources. If a data
source-specific covariate value is available, this will be
used preferentially in the models over covariates from na-
tional estimates.
Phase 1: modelling
In the first phase, the preterm birth outcome will be
modelled using a two-level (country and data source)
linear mixed regression model, including random
country-specific intercept and slope. The model will in-
clude time, data source characteristics and covariates.
Inclusion of covariates will be based on model fit param-
eters (BIC, AIC) by removing one covariate at a time
and refitting the model. If the model is improved by re-
moving the covariate, the covariate will be excluded.
Linearity will be assessed graphically per country. For
those regions that contain countries where the relation-
ship between covariates and the preterm birth outcome
is clearly not linear, a spline function or log transform-
ation will be considered. In this phase, no preterm birth
outcome data will be imputed for missing countries and/
or timepoints. Hence, the regional models will only be
based on available data. Restricted maximum likelihood
estimation (REML) will be used to develop the regional
models, and country random effects will be calculated
by best linear unbiased predictor (BLUP).
Phase 2: prediction of preterm birth rate in 2014
The predicted preterm birth rates in 2014 will be calcu-
lated based on the regional models, using country-
specific random coefficients and covariate data. Regional
and global predictions for 2014 will be calculated based
on the national estimates, weighted using number of live
births. Predictions for countries providing no preterm
birth outcome data will be based on the regional average
(i.e. random coefficients assumed to be zero) adjusted
according to country covariates. Standard errors for re-
gional and global predictions will be calculated from
country level standard error. For countries providing no
preterm birth outcome data the standard error will be
assumed to be of the same level as the country having
the largest standard error in the region.
Phase 3: presentation of results
For all countries, regions and globally the 2014 predicted
preterm birth rate will be presented together with 95 %
confidence intervals. For each country, both the reported
and the predicted preterm birth outcome data will be
graphed from the first year where data was available to
2014. Both continuous predictions and means over 5 year
periods will be presented. For countries where no pre-
term birth outcome data was identified, only the 2014
predicted value will be presented.
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Country consultation
Following the development of the preliminary estimates,
WHO will conduct an official country consultation.
WHO Member States (via their focal points) will be in-
vited to confidentially review the methodology and pre-
liminary estimates for their country. They will also be
invited to submit additional data that may not have been
identified through the searches. If additional data is
identified, it will be reviewed and included if eligible.
Subsequently, the models will be re-fit including these
new inputs.
Project management
HRP/RHR will lead the technical activities related to
data search and synthesis, as well as country consulta-
tions, in order to produce updated official WHO esti-
mates. A Technical Advisory Group (TAG) will be
established to provide oversight and technical input on
the development of these estimates. The TAG will com-
prise a group of international experts on preterm birth
estimates and modelling techniques.
Discussion
This study will be used to generate estimates of rates
and trends of preterm birth at national, regional and glo-
bal levels for 1990 to 2014. These estimates are a useful
resource for public health providers, researchers and
policymakers, in order to advance understanding the
burden of preterm birth, raise awareness and to better
target and evaluate public health programmes and track
progress.
We invite feedback on the methodology described, and
call on the public health community to submit unpub-
lished yet potentially eligible data for consideration, to
WHO via pretermbirth@who.int.
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